Healthcare supply chains carry
a risk that goes beyond cost.
Drug shortages, biologics cold chain failures, and manual GxP compliance create patient safety risk and regulatory exposure simultaneously. Groflex closes the loop — from depletion signal to governed, executed action.
The Problem
Four failure patterns unique to healthcare.
All of them compounding.
Critical medications hit zero without warning
Your procurement team gets the stockout alert when the shelf is already empty. The depletion pattern existed in your ERP for weeks. Nothing acted on it. Patient safety events follow reputational and regulatory exposure.
Biologics excursions discovered at administration
Vaccines and gene therapies have narrow temperature windows. A single excursion during cross-dock can invalidate an entire batch. Manual monitoring at 15-minute intervals misses drift. The batch is discovered as compromised at the point of administration.
High-value meds expire while sister sites are short
3–7% of hospital pharmaceutical inventory is written off annually. The same high-value medication is expiring at one facility while a sister site is on back-order. No execution layer connects the signal to a transfer or markdown.
GxP audit trails in spreadsheets and email
FDA 21 CFR Part 11 requires electronic records with timestamped, role-authenticated approvals. HACCP deviation logs must be immutable. Spreadsheets and email chains do not qualify — and your team knows it before every audit.
The Solution
From depletion signal to governed action.
GxP-governed at every step.
Real-time drug depletion and cold chain monitoring
Groflex reads inventory levels, consumption rates, and IoT temperature data continuously. It scores depletion risk per SKU and flags biologics excursions the moment a threshold is crossed.
- ERP depletion rate analysis per medication SKU
- IoT cold chain integration for biologics and vaccines
- Expiry risk scoring across all facilities simultaneously
AI reasoning against your formulary and GxP policy
The platform evaluates inter-facility transfer options, emergency procurement, and protocol-based substitutions against your formulary policy, contract pricing, and regulatory constraints before routing anything.
- Formulary-aware substitution recommendations
- Cost vs. risk tradeoff scoring per option
- Regulatory constraint checks before any recommendation
Clinically authorised approval with 21 CFR Part 11 trail
Every corrective action routes to the right authority — Pharmacy Director, Quality Manager, Clinical Lead. The approval is electronic, timestamped, role-authenticated, and immutable. No approval = no action.
- Designed for FDA 21 CFR Part 11 electronic approval
- HACCP deviation documentation auto-generated
- Role matrix: Pharmacy, Quality, Clinical, Finance
Approved actions write directly into pharmacy ERP
Inter-facility transfers, emergency POs, and quality holds execute in your system immediately after approval. No manual re-entry. No copy-paste. The system of record is updated in real time.
- Oracle SCM, SAP, and pharmacy system integration
- Transfer order and emergency PO creation
- Quality hold placement and lot quarantine execution
One-click FDA and JCAHO traceability packages
Every signal, recommendation, approval, and action is logged with timestamp, user ID, lot number, and clinical context. FDA inspection-ready packages can be generated for any event, any time.
- FDA 21 CFR Part 11 audit log — immutable
- HACCP and GxP deviation record auto-generation
- Exportable packages for FDA, JCAHO, internal auditors
What changes on day one
What healthcare operators see in 90 days
Reduction in drug shortage events (pilot avg.)
Biologics excursions reaching administration
21 CFR Part 11 audit trail coverage
Detection to pharmacist approval
Live Platform View
What your pharmacovigilance team sees
Drug shortage prevention, cold chain integrity, and 21 CFR audit trail — all in one governed platform.
See Groflex in your healthcare supply chain
4–6 week pilot. Read-only integration first. First GxP-aligned execution by week 4.